{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-198362","form_type":"8-K","ticker":"FNCHQ","cik":"0001733257","company_name":"Finch Therapeutics Group, Inc.","filed_at":"2024-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.349380+00:00","generated_at":"2026-05-31T10:05:08.262693+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Jury awards Finch $25M upfront plus royalties in patent infringement verdict against Ferring","bullets":["Jury found Ferring willfully infringed on Finch/UMN patents for microbiome therapy Rebyota.","Damages include $25.0M upfront payment and $0.815M in running royalties through trial date.","Two claims (one from '309, one from '080 patents) were found invalid; remaining claims valid.","Finch expects Ferring to file post-trial motions and appeal the judgment.","Trial began Aug 5, 2024; verdict rendered Aug 9, 2024 in U.S. District Court for Delaware."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-198362","json":"https://secwatch.observer/filing/0001193125-24-198362.json","markdown":"https://secwatch.observer/filing/0001193125-24-198362.md","text":"https://secwatch.observer/filing/0001193125-24-198362.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1733257/000119312524198362/0001193125-24-198362-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1733257/000119312524198362/d801504d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:05:08.262693+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}